The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
Some people recommend injections, but we don't
As an agonist, the drug mimics the effect of the natural hormone, boosting the effects of the natural hormone
5bt and 6, and Supplementary Video 1)
AhmadIZaldivarFIwanagaKKoeppelRGrochowDNemetDet alInflammatory and growth mediators in growing preterm infants